Meeting Program (Draft)

Updated May 19, 2022

Friday, June 3, 2022

1:00                Opening Ceremony– Dr. Richard Hillman, President of IANS

1:15 Introduction by Farrah Fawcett Foundation: Alana Stewart, CEO of the Farrah Fawcett Foundation 
Farrah Fawcett Foundation Keynote Address – 
Treatment of anal cancer and the development of specific tumor markers – Dr. Karen-Lise Garm Spindler

2:00         Oral Abstract Session - Epidemiology and natural history  - Session Chair

Gary Clifford

Predictors of anal high-grade squamous intraepithelial lesions after two years of cytological and histological follow-up in men who have sex with men living with HIV

Sameer V. Gopalani

Incidence trends for HPV-associated anal squamous cell carcinoma in the United States, 1999-2018.

Ramon P. van der Zee

Recent trends in incidence and risk factors of anal cancer in HIV-infected patients in the Netherlands: improved cancer survival in patients diagnosed with anal cancer while in screening

2:35         Novel host determinants of HPV-related diseases can inform new treatment strategies - 
Dr. Andrea Lisco

3:15 Coffee Break

3:30 Quick-Hit Abstract Session - Screening and diagnostics and Epidemiology/natural history –  Session Chair

Danielle R. L. Brogden

The incidences and disease patterns of HPV related cancers in England.

Ben Cardenas

Evaluating the cascade of care for anal cancer screening within a Ryan White HIV/AIDS program clinic

Megan A. Clarke

The Anal Cancer Etiology and Screening (ACES) Study: Design and Baseline Characteristics

Richard Gilson

Screening and early detection to prevent anal cancer (SEPAC): protocol and progress report

3:55 What is happening with anal cancer precursors in low/middle income countries - Dr. Valeria Fink

4:30 HPV vaccination among gay, bisexual, and other men who have sex with men – 
Dr. 
Ann Burchell 

5:00 Leveraging existing surveillance systems and creating new ones for anal cancer: Perspectives from the CDC– Dr. Mona Saraiya

5:15 Research Review Panel: Large cohort/treatment studies from around the world
Professor Andrew Grulich, Dr. Mary Poynten, and Dr. Tamzin Cuming

6:15  - 7:15    Opening Reception & Poster Session

Saturday, June 4, 2022

8:00 Working IANS Breakfast 

9:00 Multizonal disease
Dr. Michelle Khan and Dr. Bernadette Cracchiolo
Session Chair

9:30 ANCHOR Keynote Address: Results of the ANCHOR Study – Professor Joel Palefsky 

10:30 Anal HPV and cancer epidemiology – what’s new – Dr. Gary Clifford

10:55 Coffee Break 

11:10 Oral Abstracts Session – Screening and Diagnostics 

Camryn Cohen

Automated evaluation of p16/Ki-67 dual stain cytology improves detection of anal precancer in MSM living with HIV

Michael Gaisa

Genital and anal cytology-HPV cotesting results and prediction nomogram for anal high-risk HPC infection in women living with HIV

Fernando Dias Gonçalves Lima

Host cell DNA methylation analysis on minimally invasive anal swabs for the detection of HGAIN and anal cancer in HIV+ MSM

Keith Sigel

Anal Dysplasia Screening in People with HIV Younger than 35

12:00 Lunch on own & Poster Session

1:20 Quick-Hit Abstract Session – Session Chair

Jonathan Baker

Experience of implementing an HIV preexposure prophylaxis (PrEP) program into an anal dysplasia-focused office.

Eugenio Nelson Cavallari

Reduction of Intraepithelial NK cells Characterizes Anal Dysplasia of Any Grade in HIV+/HPV+ Subjects

Amit Gupta

Awareness of outpatient anal cancer screening among men who have sex with men living with HIV in Canada: The HPV Screening and Vaccine Evaluation (HPV-SAVE) Study

Hillary Johnson

The efficacy of topical Dihydroartemisinin to treat anal dysplasia in mice

Hamish Urquhart

Anal Squamous Cell Carcinoma (ASCC) treated by excision alone results in higher rates of HSIL, and high-risk HPV genotypes when compared to chemoradiotherapy

1:55 IANS Guidelines Update  - Dr. Naomi Jay, Dr. Elizabeth Stier, Dr. Megan Clarke and 
Dr.Gary Clifford

2:35 Inside the Guidelines Development Process – Dr. Laura Bachmann

2:50 Oral Abstract Session – Screening and Diagnostics  - Session Chairs

Tamzin Cuming 

The value of high resolution anoscopy (HRA) in the early diagnosis of anal cancer in a high-risk cohort

Yuxin Liu

HPV Testing Differentiates Metastatic Anal Cancer in the Lung from Primary Lung Cancer

Nick Matolka

Performance of 2 different High-Risk HPV assays to predict high-grade squamous intraepithelial lesions (HSIL) on high-resolution anoscopy (HRA).

3:30 Coffee Break

3:45 Natural history and biomarkers of HPV-related cancers: A comparison between anus and cervix –
Dr. Nicolas Wentzensen

4:15 ANCHOR Panel Review – Professor Joel Palefsky, Dr. Gary Clifford, 
Professor Andrew Grulich, Chair: Tamzin Cuming

5:00 Meeting Ends

6:00                 “A Night at the Opera” Optional Social Activity 

Sunday, June 5, 2022

8:00                 Breakfast/IANS Membership Meeting (IANS Members only)  

9:00 Oral Abstract Session – Session Chair

Naomi Jay

Developing Remote High Resolution Anoscopy Training

Helle Kiellberg Larsen

Risk of anal human papillomavirus infection in kidney transplant recipients compared with immunocompetent controls

Danielle R. L. Brogden

Is local excision alone for early Anal Squamous Cell Carcinoma (ASCC) efficacious in people living with HIV (PLWH)?

9:35 Contemporary patterns in anal cancer incidence and mortality and integration into mathematical modeling to inform guidelines and clinical practice – Dr. Ashish Deshmukh

10:15 Coffee Break

10:30 Patient Panel 
Rare and Misunderstood: Ten Years Later - Narratives and Perspective on the Anal Cancer Experience with: Daun Ricci, Steven Post, Dr. Stephen Weitzman, John Kneapler and Justine Almada
Session Chair: Mary-Jo Murphy

11:30 Lunch on own 

1:15 Early Anal Cancer Group – Dr. J. Michael Berry-Lawhorn
Session Chair

1:30 Expanding HRA Education and Services in the Post-ANCHOR World – Dr. Tamzin Cuming, Dr. Michelle Khan, and Dr. Cristina Brickman

2:00 10 years of IANS  - Professor Joel, Palefsky, Dr. Stephen Goldstone and  Dr. Naomi Jay

2:30 – 3:00 Wrap up, closing ceremony – Dr. Luis Barroso

The International Anal Neoplasia Society

P.O. Box 1543
Leesburg, Virginia 20177

info@iansociety.org

Powered by Wild Apricot Membership Software